Harrow, Inc. (HROW)
35.21
-0.18
(-0.51%)
USD |
NASDAQ |
May 29, 16:00
35.50
+0.29
(+0.82%)
After-Hours: 20:00
Harrow Shareholders Equity (Quarterly) : 28.71M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.20B |
| Liquidia Corp. | 108.58M |
| Corcept Therapeutics, Inc. | 637.99M |
| Esperion Therapeutics, Inc. | -307.93M |
| Theravance Biopharma, Inc. | 290.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 419.54M |
| Total Liabilities (Quarterly) | 391.19M |
| Debt to Equity Ratio | 10.47 |
| Current Ratio | 2.476 |
| Net Debt Paydown Yield | -1.09% |